Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
NAR Cancer
|
September 27, 2021
Correction to 'Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer'
Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Journal of Translational Medicine
|
July 25, 2024
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
Habib Sadeghirad, James Monkman, Chin Wee Tan, et al.
NAR Cancer
|
July 28, 2021
Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer
Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Communications Biology
|
May 29, 2021
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Katrina Kildey, Neha S Gandhi, Katherine B Sahin, et al.
Frontiers in Immunology
|
May 8, 2023
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
Habib Sadeghirad, Ning Liu, James Monkman, et al.
Nature Communications
|
December 5, 2019
Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage
Emma Bolderson, Joshua T Burgess, Jun Li, et al.
Frontiers in Oncology
|
March 29, 2021
Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
Sarah-Louise Ryan, Keyur A Dave, Sam Beard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
Sarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
British Journal of Cancer
|
January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
Esha T Shah, Christopher Molloy, Madeline Gough, et al.
The Prostate
|
February 22, 2023
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer
Mark N Adams, Laura V Croft, Aaron Urquhart, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
NAR Cancer
|
September 27, 2021
Correction to 'Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer'
Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Journal of Translational Medicine
|
July 25, 2024
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
Habib Sadeghirad, James Monkman, Chin Wee Tan, et al.
NAR Cancer
|
July 28, 2021
Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer
Adrian P Wiegmans, Ambber Ward, Ekaterina Ivanova, et al.
Communications Biology
|
May 29, 2021
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Katrina Kildey, Neha S Gandhi, Katherine B Sahin, et al.
Frontiers in Immunology
|
May 8, 2023
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
Habib Sadeghirad, Ning Liu, James Monkman, et al.
Nature Communications
|
December 5, 2019
Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage
Emma Bolderson, Joshua T Burgess, Jun Li, et al.
Frontiers in Oncology
|
March 29, 2021
Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
Sarah-Louise Ryan, Keyur A Dave, Sam Beard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
Sarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
British Journal of Cancer
|
January 29, 2024
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
Esha T Shah, Christopher Molloy, Madeline Gough, et al.
The Prostate
|
February 22, 2023
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer
Mark N Adams, Laura V Croft, Aaron Urquhart, et al.
Page
of 6